Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 732195, 7 pages
http://dx.doi.org/10.1155/2012/732195
Research Article

Reliability and External Validity of AMSTAR in Assessing Quality of TCM Systematic Reviews

1Department of Evidence-Based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University, Chengdu 610041, China
2Department of Medical Information, Zigong Third People’s Hospital of Zigong City, 643000 Zigong, China

Received 1 October 2011; Revised 29 November 2011; Accepted 6 December 2011

Academic Editor: Alfredo Vannacci

Copyright © 2012 Deying Kang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Hu, J. Qiao, D. Kang, and B. Liu, “Analysis on the distinguishing features of traditional Chinese therapeutics and related statistical issues,” Frontiers of Medicine in China, vol. 5, no. 2, pp. 203–207, 2011. View at Publisher · View at Google Scholar
  2. Z. Junhua, S. Hongcai, G. Xiumei et al., “Methodology and reporting quality of systematic review/meta-analysis of traditional Chinese medicine,” Journal of Alternative and Complementary Medicine, vol. 13, no. 8, pp. 797–805, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Ma, J. Guo, G. Qi et al., “Epidemiology, quality and reporting characteristics of systematic reviews of traditional Chinese medicine interventions published in Chinese journals,” PLoS One, vol. 6, no. 5, Article ID e20185, 2011. View at Publisher · View at Google Scholar
  4. P. Katrak, A. E. Bialocerkowski, N. Massy-Westropp, V. S. S. Kumar, and K. A. Grimmer, “A systematic review of the content of critical appraisal tools,” BMC Medical Research Methodology, vol. 4, article no. 22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. B. J. Shea, J. M. Grimshaw, G. A. Wells et al., “Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews,” BMC Medical Research Methodology, vol. 7, article no. 10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. D. Oxman and G. H. Guyatt, “Validation of an index of the quality of review articles,” Journal of Clinical Epidemiology, vol. 44, no. 11, pp. 1271–1278, 1991. View at Publisher · View at Google Scholar · View at Scopus
  7. H. S. Sacks, J. Berrier, and D. Reitman, “Meta-analyses of randomized controlled trials,” New England Journal of Medicine, vol. 316, no. 8, pp. 450–455, 1987. View at Google Scholar · View at Scopus
  8. B. J. Shea, C. Hamel, G. A. Wells et al., “AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews,” Journal of Clinical Epidemiology, vol. 62, no. 10, pp. 1013–1020, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Alderson, S. Green, and J. P. T. Higgins, Cochrane Reviewers' Handbook 4.2.2, The Cochrane Library, Issue 1, John Wiley & Sons, Chichester, UK, 2004.
  10. D. Hu, D. Y. Kang, Y. X. Wu, and J. L. Wang, “Methodological quality assessment of systematic reviews correlated to Traditional Chinese Medicine published in China,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 31, no. 3, pp. 402–406, 2011. View at Google Scholar
  11. Y. F. Cai, Y. Xu, J. W. Guo, and Y. Huang, “Meta-analysis on random control tests of Huatuo Reconstruction Pill in treating ischemic stroke,” Chinese Traditional and Herbal Drugs, vol. 38, no. 4, pp. 185–188, 2007. View at Google Scholar
  12. J. Chen, H. Y. Chen, Z. C. Liu, and T. X. Wu, “Effect and safety of Yinzhihuang injection for icteric viral hepatitis: a systematic review,” Chinese Journal of Evidence-Based Medicine, vol. 5, no. 6, pp. 461–465, 2005. View at Google Scholar · View at Scopus
  13. Y. Chen and M. Liu, “Systemic evaluation of security of ligustrazine for treatment of cerebral infarction,” Chinese Journal of Clinical Rehabilitation, vol. 8, no. 7, pp. 1299–1301, 2004. View at Google Scholar · View at Scopus
  14. J. M. Fan, L. S. Liu, Z. Li, B. H. Su, and J. Guan, “A Meta-analysis of Radix Astragali for primary nephrotic syndrome in adults,” Journal of Chinese Medicine and Clinical Pharmacology, vol. 14, no. 1, pp. 62–66, 2003. View at Google Scholar
  15. X. F. Guo and S. L. Lai, “Meta-analysis of Qingkailing injection for treating acute stroke,” Journal of Guangzhou University of Traditional Chinese Medicine, vol. 17, no. 1, pp. 9–14, 2000. View at Google Scholar
  16. H. J. He, L. Z. Xu, S. W. Li, and Y. P. Li, “Effects of Chinese herbs for female immune-caused subfertility: a systematic review,” Chinese Journal of Evidence-Based Medicine, vol. 4, no. 9, pp. 609–614, 2004. View at Google Scholar
  17. K. J. Li, “Meta analysis of Buyanghuanwu decoction on treating apoplexy,” Tianjin Journal of Traditional Chinese Medicine, vol. 23, no. 5, pp. 372–376, 2006. View at Google Scholar
  18. K. J. Li, “System evaluation of randomized controlled trial on Mailuoning injection in treating acute stage of ischemic apoplexy,” Journal of Traditional Chinese Medicine, vol. 21, no. 8, pp. 174–177, 2006. View at Google Scholar
  19. K. J. Li, “Systemic appraisal and research of random control test of dizziness of vertebrobasilar ischemia treated with Buyang Huangwu Tang,” Journal of Zhejiang University of Traditional Chinese Medicine, vol. 31, no. 5, pp. 175–177, 2007. View at Google Scholar
  20. J. P. Liu, E. Manheimer, and Y. Shi, “Systematic review and meta-analysis on the integrative traditional Chinese and Western medicine in treating SARS,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 25, no. 12, pp. 1082–1088, 2005. View at Google Scholar · View at Scopus
  21. X. Q. Liu, G. H. Yao, S. F. Yang, and M. Lu, “Systematic review of Chinese medicine herbs against NSAIDS for knee osteoarthritis,” Chinese Archives of Traditional Chinese Medicine, vol. 23, no. 6, pp. 1008–1011, 2005. View at Google Scholar
  22. M. B. Meng, Y. L. Cui, Y. S. Guan, B. She, and R. M. Zhang, “Traditional Chinese medicine plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials,” Chinese Journal of Evidence-Based Medicine, vol. 8, no. 1, pp. 21–31, 2008. View at Google Scholar · View at Scopus
  23. Y. Ren, K. J. Chen, and X. M. Ruan, “Systematic review of randomized controlled trials on preventing and treating restenosis after percutaneous coronary intervention with Chinese medicine,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 28, no. 7, pp. 597–601, 2008. View at Google Scholar · View at Scopus
  24. Y. Ren, K. J. Chen, X. M. Ruan et al., “Meta-analysis of Chinese herb of promoting blood circulation to dissipate blood stasis in preventing and treating restenosis after percutaneous Coronary Intervention,” Liaoning Journal of Traditional Chinese Medicine, vol. 35, no. 5, pp. 146–149, 2008. View at Google Scholar
  25. J. Shi, C. W. Wang, and K. Fan, “Meta-analysis of the effectiveness of Tong Xie Yao Fang in treating irritable bowel syndrome,” Shijie Huaren Xiaohua Zazhi, vol. 15, no. 17, pp. 1934–1939, 2007. View at Google Scholar
  26. X. C. Tang, X. F. Guo, L. Luo, A. H. Ou, and S. L. Lia, “Shuang Huang Lian for acute respiratory infections: a meta analysis,” Chinese Archives of Traditional Chinese Medicine, vol. 20, no. 3, pp. 298–301, 2002. View at Google Scholar
  27. H. R. Wang, X. B. Qin, and L. Wang, “Systematic investigation of Angong Niuhuang Wan against pulmonary encephalopathy,” Chinese Traditional and Herbal Drugs, vol. 34, no. 1, pp. 92–93, 2003. View at Google Scholar
  28. J. S. Wang, J. H. Zhang, H. Y. Hu et al., “SAN Qi and compound DAN SHEN injection for cerebral infarction,” Chinese Journal of Hospital Pharmacy, vol. 26, no. 3, pp. 317–319, 2006. View at Google Scholar
  29. L. Wang, S. Zhou, J. Shao, and S. Zhang, “System review of the Chinese medicine bushenhuoxue for treating benign prostatic hyperplasia,” National Journal of Andrology, vol. 10, no. 10, pp. 785–789, 2004. View at Google Scholar · View at Scopus
  30. W. X. Wang and K. J. Chen, “Xuezhikang capsule for hyperlipidemia: a systematic review,” Chinese Journal of Evidence-Based Medicine, vol. 6, no. 5, pp. 352–360, 2006. View at Google Scholar · View at Scopus
  31. X. Wang, Y. Y. Zhu, and L. S. Hu, “Chinese medicine for vascular dementia: a systematic review,” Journal of Nanjing TCM University, vol. 22, no. 3, pp. 181–183, 2006. View at Google Scholar
  32. Y. Xia and J. P. Liu, “Glycyrrhizin and derivatives for treatment of chronic hepatitis B: a systematic review of randomized controlled trials,” Journal of Integrated Traditional and Western Medicine on Liver Diseases, vol. 17, no. 5, pp. 403–409, 2007. View at Google Scholar
  33. Y. M. Xie, Y. Y. Zhu, and T. X. Wu, “Effects and safety of traditional Chinese medicine for treating postmenopausal osteoporosis: a systematic review,” Chinese Journal of Evidence-Based Medicine, vol. 5, no. 1, pp. 29–74, 2005. View at Google Scholar · View at Scopus
  34. J. Xiong, J. S. Song, and T. G. Shang, “Xuanfu Daizhe decoction for treatment of reflux esophagitis: a systematic review of randomized controlled trials,” Journal of Practical Traditional Chinese Internal Medicine, vol. 22, no. 1, pp. 91–93, 2008. View at Google Scholar
  35. F. L. Xu, L. X. Gao, T. X. Wu, and J. H. Ding, “Clinical efficacy and safety of Xingnaojing injection for cerebral infarction: a systematic review,” Chinese Journal of Evidence-Based Medicine, vol. 5, no. 7, pp. 549–565, 2005. View at Google Scholar · View at Scopus
  36. W. H. Xu and Z. H. Wen, “Tripterygium for rheumatoid arthritis: a meta-analysis,” Journal of Chinese Medicine and Clinical Pharmacology, vol. 12, no. 6, pp. 410–413, 2001. View at Google Scholar
  37. L. Zheng, H. X. Liu, and J. J. Shang, “Intravenous formulation of traditional Chinese medicine for acute myocardial infarction: a meta- analysis,” Journal of Emergency of TCM, vol. 16, no. 7, pp. 859–862, 2007. View at Google Scholar
  38. F. H. Zhao, B. Ma, K. Yi et al., “Yangxue Qingnao Grain for migraine: a systematic review,” Chinese Journal of Evidence-Based Medicine, vol. 8, no. 10, pp. 887–891, 2008. View at Google Scholar · View at Scopus
  39. Z. F. Yuan, X. Sun, Y. Meng, Y. Y. Jing, X. Mao, and Y. P. Li, “A systematic review of randomized trials of artesunate for severe malaria,” Chinese Journal of Evidence-Based Medicine, vol. 7, no. 11, pp. 794–801, 2007. View at Google Scholar · View at Scopus
  40. Y. Tan, M. Liu, and B. Wu, “Clinical efficacy of pueraria for acute cerebral infarction,” Chinese Journal of Evidence-Based Medicine, vol. 6, no. 7, pp. 494–499, 2006. View at Google Scholar · View at Scopus
  41. X. Jian, J. M. Fan, Z. Li, H. Luo, and B. H. Su, “Ligustrazine for primary nephritic syndrome: a systematic review,” Chinese Journal of Evidence-Based Medicine, vol. 4, no. 8, pp. 627–633, 2004. View at Google Scholar
  42. M. He and J. Jiang, “Traditional Chinese Medicine and sulfasalazine for ulcerative colitis: a meta-analysis,” Liaoning Journal of Traditional Chinese Medicine, vol. 34, no. 11, pp. 1582–1583, 2007. View at Google Scholar
  43. V. Chung, L. Liu, Z. Bian et al., “Efficacy and safety of herbal medicines for idiopathic Parkinson's disease: a systematic review,” Movement Disorders, vol. 21, no. 10, pp. 1709–1715, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Wu, R. A. Harrison, X. Chen et al., “Tongxinluo (Tong xin luo or Tong-xin-luo) capsule for unstable angina pectoris,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD004474, 2006. View at Google Scholar · View at Scopus
  45. J. P. Liu, M. Yang, and X. M. Du, “Herbal medicines for viral myocarditis,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD003711, 2004. View at Google Scholar · View at Scopus
  46. B. Wu, M. Liu, and S. Zhang, “Dan Shen agents for acute ischaemic stroke,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD004295, 2007. View at Google Scholar · View at Scopus
  47. J. P. Liu, H. McIntosh, and H. Lin, “Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD002231, 2001. View at Google Scholar · View at Scopus
  48. J. Wei, J. Ni, T. Wu et al., “Chinese medicinal herbs for acute bronchitis,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD004560, 2008. View at Google Scholar · View at Scopus
  49. W. Dengfeng, W. Taixiang, H. Lina et al., “Chinese herbal medicines in the treatment of ectopic pregnancy,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD006224, 2007. View at Google Scholar · View at Scopus
  50. Y. Chen, J. J. Guo, D. P. Healy, and S. Zhan, “Effect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: a meta-analysis,” Pharmacy Practice, vol. 5, no. 1, pp. 1–9, 2007. View at Google Scholar · View at Scopus
  51. M. M. Zhang, X. M. Liu, and L. He, “Effect of integrated traditional Chinese and Western medicine on SARS: a review of clinical evidence,” World Journal of Gastroenterology, vol. 10, no. 23, pp. 3500–3505, 2004. View at Google Scholar · View at Scopus
  52. B. Shea, D. Moher, I. Graham, B. Pham, and P. Tugwell, “A comparison of the quality of Cochrane reviews and systematic reviews published in paper-based journals,” Evaluation and the Health Professions, vol. 25, no. 1, pp. 116–129, 2002. View at Publisher · View at Google Scholar · View at Scopus